Marianne van der Steen

Director/Miembro de la Junta en Neuroplast BV .

Health Technology

Perfil

Marianne van der Steen has current job(s) as a member of the supervisory board at Neuroplast BV.

Empresas	Cargo	Inicio
Neuroplast BV Neuroplast BV BiotechnologyHealth Technology Neuroplast BV is a Dutch stem cell technology company that focuses on developing autologous cell products for the treatment of primarily inflammation-driven neurological disorders. Neuroplast is located in Brightlands Chemelot Campus in the Netherlands. The company's transformative treatment, Neuro-cellsò, is currently being tested for traumatic spinal cord injury (TSCI) and aims to reduce the irreversible impact of TSCI during the crucial first phase. The company was founded in August 2014 by physician De Munter and neurologist Erik Wolters, and current investors include Invest, Brightlands Venture Partners, and Liof NV. Johannes de Munter has been the CEO of the company since 2016.	Director/Miembro de la Junta	-

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Relaciones de 1er grado

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Empresas privadas	1
Neuroplast BV Neuroplast BV BiotechnologyHealth Technology Neuroplast BV is a Dutch stem cell technology company that focuses on developing autologous cell products for the treatment of primarily inflammation-driven neurological disorders. Neuroplast is located in Brightlands Chemelot Campus in the Netherlands. The company's transformative treatment, Neuro-cellsò, is currently being tested for traumatic spinal cord injury (TSCI) and aims to reduce the irreversible impact of TSCI during the crucial first phase. The company was founded in August 2014 by physician De Munter and neurologist Erik Wolters, and current investors include Invest, Brightlands Venture Partners, and Liof NV. Johannes de Munter has been the CEO of the company since 2016.	Health Technology

Empresas privadas

Health Technology